Physician profile
Mark Hartzband
NPI 1386639722
$9,383,041.26
in general payments reported to CMS, 2019-2025
4 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935K · 2020: $892K · 2021: $1.3M · 2022: $987K · 2023: $5.3M · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.3M · Consulting Fee: $2,700 · Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,312,293.68 |
| Consulting Fee | $2,700.00 |
| Food and Beverage | $272.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $9,348,237.81 | 2019-2023 | Persona |
| Encore Medical, Lp | $34,664.49 | 2019-2025 | Djo Surgical |
| Microport Orthopedics INC | $123.96 | 2019 | |
| Pfizer INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hartzband listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.